Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

A protective role for HIF-1 in response to redox manipulation and glucose deprivation: implications for tumorigenesis

Abstract

We have investigated the role of HIF-1 in the cellular response to redox modulation via the inhibition of oxidative phosphorylation. We demonstrate that manipulation of redox in air, achieved by inhibiting cytochrome oxidase with cyanide, induces HIF-1 mediated transcription in wild-type CHO and HT1080 human tumour cells but not in CHO cells deficient in the oxygen responsive, HIF-1α sub-unit of HIF-1. Hypoglycaemia attenuates cyanide-mediated transcription in non-transformed HIF-1 wild-type CHO cells but not the human tumour derived cell line. Cells lacking either HIF-1α, or the second composite sub-unit of HIF-1, HIF-1β, were markedly more sensitive to the combined stress of perturbed redox and hypoglycaemia than wild-type cells. As such conditions together with hypoxia are prevalent in tumours, these data suggest that HIF-1 may have a protective role in adaptation to the tumour micro-environment. In support of this we demonstrate that HIF-1α deficient cells are less tumorigenic than wild-type cells. They showed a reduced growth rate when grown as xenografts in nude mice. This was not related to vascular parameters that were identical to those found in HIF-1 wild-type tumours. The HIF-1 deficient tumours lacked focal expression of Glut-1 in hypoxic tumour regions. Compromized glucose uptake and metabolic adaptation to the tumour micro-environment may form the basis of the reduced tumorigenecity associated with these cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Agani FH, Pichiule P, Chavez JC, La Manna JC . 2000 J. Biol Chem. 275: 35863–35867

  • Airley R, Loncaster J, Davidson S, Bromley M, Roberts S, Patterson A, Stratford IJ, West C . 2001 Clin. Cancer Res. 7: 928–934

  • Behrooz A, Ismail-Beigi F . 1997 J. Biol. Chem. 272: 5555–5562

  • Blancher C, Moore JW, Talks KL, Houlbrook S, Harris AL . 2000 Cancer Res. 60: 7106–7113

  • Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G . 2000 Cancer Res. 60: 4693–4696

  • Brown RS, Leung JY, Fisher SJ, Frey KA, Ethier SP, Wahl RL . 1996 J. Nucl. Med. 37: 1042–1047

  • Bussink J, Kaanders JHAM, Rijken PFJW, Martindale CA, van der Kogel AJ . 1998 Br. J. Cancer 77: 57–64

  • Carmeliet P, Dor Y, Herbert J-M, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe PJ, Moons L, Jain RK, Collen D, Keshet E . 1998 Nature 394: 485–490

  • Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, Schumacker PT . 1998 Proc. Natl. Acad. Sci. USA 95: 11715–11720

  • Chandel NS, McClintock DS, Feliciano CE, Wood TM, Melendez JA, Rodriguez AM, Schumacker PT . 2000 J. Biol. Chem. 275: 25130–25138

  • Chung JK, Lee YJ, Kim C, Choi SR, Kim M, Lee K, Jeong JM, Lee DS, Jang JJ, Lee MC . 1999 J. Nucl. Med. 40: 339–446

  • Dachs GU, Patterson AV, Firth JD, Ratcliffe PJ, Townsend KMS, Stratford IJ, Harris AL . 1997 Nature Med. 3: 515–520

  • Dang CV, Lewis BC, Dolde C, Dang G, Shim H . 1997 J. Bioenerget. Biomembranes 29: 345–354

  • Griffiths JR, McSheehy PMJ, Robinson SP, Troy H, Chung Y-L, Jackson D, Williams KJ, Stratford IJ, Stubbs M . Cancer Res. in press

  • Hodgkiss RJ, Jones G, Long A, Parrick J, Smith KA, Stratford MRL, Wilson GD . 1991 Br. J. Cancer 63: 119–125

  • Ivan M, Kondo K, Yang H, Kim W, Valiandro J, Ohh M, Salic A, Asara JM, Lane WS, Kaelin WG . 2001 Science 292: 464–468

  • Jaakkola P, Mole DR, Tian Y-M, Wilson MI, Gielbert J., Gaskell SJ, von Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ . 2001 Science 292: 468–472

  • Jiang B-H, Agani F, Passaniti A, Semenza GL . 1997 Cancer Res. 57: 5328–5335

  • Maxwell PH, Dachs GU, Gleadle JM, Nicholls LG, Harris AL, Stratford IJ, Hankinson O, Pugh CW, Ratcliffe PJ . 1991 Proc. Natl. Acad. Sci. USA 94: 8104–8109

  • Necas E, Thornling EB . 1972 Am. J. Physiol. 22: 1187–1190

  • Pugh CW, Tan CC, Jones RW, Ratcliffe PJ . 1991 Proc. Natl. Acad. Sci. USA 88: 10553–10557

  • Raleigh JA, Chou SC, Arteel GE, Horsman MR . 1999 Radiat. Res. 151: 580–589

  • Ratcliffe PJ, O'Rourke JF, Maxwell PH, Pugh CW . 1998 J. Exp. Biol. 201: 1153–1162

  • Ryan HE, Lo J, Johnson RS . 1998 EMBO. J. 17: 3005–3015

  • Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M, Arbeit JM, Johnson RS . 2000 Cancer Res. 60: 4010–4015

  • Srinivas V, Leshchinsky I, Sang N, King M, Minchenko A, Caro J . 2001 J. Biol. Chem. 276: 21995–21998

  • Stratford IJ, Patterson AV, Dachs GU, Telfer B, Williams KJ . 1999 Tumour hypoxia: pathophysiology, clinical significance and therapeutic perspectives Vaupel P and Kelleher DK (eds) Wissenschaftliche verlagsgesellschaft mbh: Stuttgart pp. 107–113

    Google Scholar 

  • Tan CC, Ratcliffe PJ . 1991 Am. J. Physiol. 261: F982–F987

  • Tian H, McKnight SL, Russell DW . 1997 Genes Dev. 11: 72–82

  • Teicher BA . 1994 Cancer Metas. Rev. 13: 139–168

  • Wood SM, Gleadle JM, Pugh CW, Hankinson O, Ratcliffe PJ . 1996 J. Biol. Chem. 271: 15117–15123

  • Wood SM, Wiesener MS, Yeates KM, Okada N, Pugh CW, Maxwell PH, Ratcliffe PJ . 1998 J. Biol. Chem. 273: 8360–8368

  • Zelzer E, Levy Y, Kahana C, Shilo BZ, Rubenstein M, Cohen B . 1998 EMBO. J. 17: 5085–5094

  • Zhong H, Agani F, Baccala AA, Laughner E, Rioseco-Camacho N, Isaacs WB, Simons JW, Semenza GL . 1998 Cancer Res. 58: 5280–5284

  • Zhong H, De Marzo A, Laughner E, Lim M, Hilton DA, Zagzag D, Buecherler P, Isaacs WB, Semenza GL, Simons JW . 1999 Cancer Res. 59: 5830–5835

Download references

Acknowledgements

Thanks are due to Professor Peter Ratcliffe for supplying cell lines and for critically reviewing these studies. The collaboration with Albert van der Kogel was initiated via the Biomed II Concerted Action Programme (Development of Methods for the Rapid Analysis of Tumour Oxygenation to Allow Treatment Stratification; contract BMH4983006). This work was funded by the Medical Research Council.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kaye J Williams.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Williams, K., Telfer, B., Airley, R. et al. A protective role for HIF-1 in response to redox manipulation and glucose deprivation: implications for tumorigenesis. Oncogene 21, 282–290 (2002). https://doi.org/10.1038/sj.onc.1205047

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205047

Keywords

This article is cited by

Search

Quick links